RecipharmCobra Biologics and KAHR Medical announced a continuation of their partnership agreement.
Nycomed announced it has completed the transfer of marketing authorization approvals in a number of key Asia-Pacific markets for osteoporosis treatment Bonviva (Ibandronate).
There are new genetic clues on risk factors and biological causes of a rare neurodegenerative disease called progressive supranuclear palsy (PSP), according to a study from led by Perelman School of Medicine at the University of Pennsylvania researchers.
Mayo Clinic investigators and United Kingdom collaborators cured well-established prostate tumors in mice.
Yale School of Medicine researchers report a single gene is central in the development of several forms of polycystic kidney and liver disease.
Accelrys, Inc., announced an enhanced and expanded Partner Program. The Accelrys Partner Program enables industry collaborators to combine their own products and services with Accelrys technologies on a single platform.
Biotechnology company Biohit has developed a electronic pipette especially suitable for dispensing small volumes of liquid. The liquid is dispensed from the pipette tip very rapidly, which ensures that the tip is completely emptied.
Grant Instruments, a supplier of precision sample preparation equipment, has recently added a General Purpose Centrifuge to their Grant-bio line of products.
Researchers have used a library of DNA to create a vaccine that could be used to treat cancer. Before now, gene therapy vaccines have often delivered just one gene to stimulate the immune system.
PROLOR Biotech, Inc. announced that its pediatric investigation plan for clinical development of its long-acting human growth hormone has been accepted for review by the Pediatric Committee of the European Medicines Agency.
Abbott announced that the U.S. Food and Drug Administration has approved a 45 mg for six-month administration formulation of Lupron Depot, a medication used for the palliative treatment of advanced prostate cancer.
Genentech announced that a Phase 2 study with vismodegib showed positive results in people with advanced basal cell carcinoma for whom surgery is considered inappropriate.
A Johnson & Johnson company is recalling lots of the antipsychotic Risperdal and its generic equivalent due to an odor that may come from a chemical preservative used in wood shipping pallets.
Pfizer Inc. and Acura Pharmaceuticals Inc. said the Food and Drug Administration approved a powerful painkiller that is designed to be harder to abuse.
Van Andel Research Institute (VARI) researchers found a protein that could help predict the spread of the head and neck cancer nasopharyngeal carcinoma (NPC) and also act as a treatment strategy to stop the spread of the disease.